Nanotechnology in Cosmetics
Nanotechnology is a growing business worldwide. Nanomaterials are increasingly used in cosmetics and personal care products. Nanomaterials are similar to other chemicals/substances, but there are risks associated to specific nanomaterials and their use. In the EU, cosmetic products containing nanomaterials may have to be notified by the Responsible Person six months before being placed on the market.

NANOMATERIALS EU LEGAL FRAMEWORK

According to the European Regulation (EC) No 1223/2009 on cosmetic products, nanomaterial means “an insoluble or bio-persistent and intentionally manufactured material whit one or more external dimensions, or an internal structure, on the scale from 1 to 100 nm”. This definition may suffer adjustments in the future by the Commission, in line with the constant technical and scientific developments seen in the field of nanotechnologies.

All cosmetic products that contain nanomaterials shall be subject to a higher level of protection of human health. This means that, when notifying a cosmetic product, the presence substances in the nano form needs to be duly identified.

Cosmetic products containing nanomaterials must be notified by the Responsible Person (by electronic means) six months before being placed on the market. They must be authorized by the European Commission prior to their use in cosmetic and personal care products. This does not apply when the nanomaterials are used as colourants, UV-filters or preservatives and are already included in the Annexes of the European Regulation (the “positive” lists).

The notification of cosmetic products containing nanomaterials has to include, at least:
• Identification of the nanomaterial (including its chemical name – IUPAC);
• Specification of the nanomaterial (size of particles, physical and chemical properties);
• Estimation of the quantity of nanomaterial contained in cosmetic products intended to be placed on the market per year;
• Toxicological profile of the nanomaterial;
• Safety data of the nanomaterial relating to the category of cosmetic product (as used in such products);
• Reasonably foreseeable exposure conditions.

If there are any concerns regarding the safety of a nanomaterial, the European Commission shall request the Scientific Committee on Consumer Safety (SCCS) to give its opinion on the safety of such nanomaterial for use in the relevant categories of cosmetic products and on the reasonably foreseeable exposure conditions. If, according to the SCCS final opinion, there is a potential risk to human health, including when there is insufficient data, the Commission shall put in place the necessary risk management measures and may amend Annexes II and III (list of prohibited substances in cosmetics and list of substances which cosmetic products must not contain except subject to the restrictions laid down).

SAFETY OF NANOMATERIALS IN COSMETICS

Until now, the concerns of the Commission that gave origin to requests of the SCCS opinions have been base on the intrinsic properties of nanomaterials, as a category, because of their nano-scale dimension, bio-persistence and insolubility.

The SCCS reviews submitted toxicological data and publishes its opinion on the safety of the ingredients in cosmetics. Several opinions on ingredients in the nano form have been published by the SCCS (like, colloidal silver, styrene/acrylates polymer, copper and colloidal copper, hydroxyapatite, silica, and others).

March this year, the European Commission’s SCCS has published a scientific advice on the safety of nanomaterials in cosmetics (SCCS/1618/20). The SCCS has identified certain aspects of nanomaterials that constitute a basis for concern over safety to consumers’ health when used in cosmetic products. Physicochemical aspects (like the very small dimensions, solubility/persistence, etc.), exposure aspects (such as frequency and amounts used, etc.) and other aspects (like novel properties, activity or function, etc.) were among the attributes considered.

Previous inconclusive opinions on three different nanomaterials were reviewed. With further relevant information available in published literature, the SCCS identified certain features related to each of the nanomaterials that raise a safety concern (described in the annexes of the scientific advice).

In sum, nanotechnology used in cosmetics may represent a step forward in innovation but it may also represent a risk to consumers health. Cosmetic companies that intend to use nanomaterials (not yet present in the Annexes of the Europeans Cosmetic Regulation) in their products must prepare a dossier with all documentation regarding these compounds. This process might be complicated and lead to increased costs for cosmetic companies

We can help you to successfully follow through this process. For more information, feel free to contact us at info@criticalcatalyst.com.

References:

  1. Regulation (EC) No 1223/2009 of the European Parliament and of the Council of 30 November 2009 on cosmetic products.
  2. Scientific Committee on Consumer Safety (SCCS). Scientific Advice on the safety of nanomaterials in cosmetics (SCCS/1618/20). Available at: https://ec.europa.eu/health/sites/health/files/scientific_committees/consumer_safety/docs/sccs_o_239.pdf

further
reading

cosmetic products

The Responsible Person in the EU

Only cosmetic products for which a Responsible Person is designated in the European Union can be placed on the EU market. The Responsible Person must ensure full compliance with the European Cosmetic Regulation.

Read More »
cosmetic products

SCCS Preliminary Opinion on Genistein and Daidzein

The European Commission Scientific Committee on Consumer Safety (SCCS) has published its preliminary opinion on the use of Genistein and Daidzein in cosmetic products. The deadline for comments was set at 14 March 2022.

Read More »
cosmetic products

The Cosmetic Products Notification Portal (CPNP)

Only cosmetic products for which a legal or natural person is designated within the EU as a “Responsible Person” can be placed on the European Union (EU) market. Before placing a cosmetic product on the EU market, the RP must notify it in the Cosmetic Products Notification Portal (CPNP).

Read More »
cosmetic products

French Anti-Waste Law

The Loi relative à la lute contre le gaspillage et a l’économie circulaire (Anti-Waste for a circular economy) has come officially into force in France in 2020. Since the beginning of this year, some requirements of the law became mandatory, like the Triman logo. The law provides for a ban on all single-use plastics by 2040.

Read More »
cosmetic products

SCCS Preliminary Opinion on 4-MBC

In 2019, the European Commission set out two lists of ingredients suspected of having endocrine disrupting properties. As 4-MBC (UV-filter) was included in the higher priority group, the European Commission asked the SCCS to carry out a safety assessment on this ingredient. The preliminary version of the requested opinion was published.

Read More »
cosmetic products

SCCS Revision of the Opinion on Vitamin A

Vitamin A is not currently included in the Annexes of the European Cosmetics Regulation (Regulation (EC) No 1223/2009). The SCCS published the preliminary version of its revision of the scientific opinion on Vitamin A (retinol, retinyl palmitate and retinyl acetate). The deadline for comments was set at 7 February.

Read More »
medical devices

Person Responsible for Regulatory Compliance (PPRC) under MDR & IVDR

The EU Medical Device Regulation (EU MDR) and the EU In Vitro Diagnostic Device Regulation (EU IVDR) require all Manufacturers and Authorized Representatives to have a designated employee in their company who is responsible for regulatory compliance with the applicable MDR or IVDR requirements, the Person Responsible for Regulatory Compliance (PRRC).

Read More »